title: [Relationship of XRCC1 polymorphism with the risks and clinicopathological factors of cervical cancer].
abstract: OBJECTIVE
  To explore the correlation of XRCC1 Arg194Trp Arg399Gln SNPs with the risks and clinicopathological factors of cervical cancer.
  
  
  METHODS
  Polymorphisms Arg194Trp, Arg399Gln of XRCC1 gene in 253 cervical cancer patients and 350 healthy controls were analyzed by mismatch amplification polymerase chain reaction (MAMA-PCR).
  
  
  RESULTS
  Compared with the Arg/Arg genotypes, the Trp/Trp genotypes could increase the risk of cervical cancer (P = 0.000) . Arg/Arg was a protection factor with an odds ratio of 0.116 (95%CI = 0.043-0.316) . The frequency of Arg and Gln allele among cervical cancer and healthy controls were 56.81%, 43.19% and 64.86%, 35.14%. Compared with the Arg genotypes, the Gln genotypes could increase the risk of cervical cancer (P < 0.05) . Compared with the Arg/Arg genotypes, the Gln/Gln genotypes could increase the risk of cervical cancer (P < 0.01) . Arg/Arg was a protection factor with an odds ratio of 0.188 (95%CI = 0.089-0.398) . Using haplotypes 194Trp-399Gln as a reference, women carrying 194Arg-399Gln and 194Arg-399Arg halpotypes had a significantly decreased risk for cervical carcinoma. The adjusted OR and 95%CI were 0.613 [0.446, 0.842] and 0.635 [0.449, 0.899]. The frequencies of Arg/Arg, Arg/Gln, Gln/Gln genotype had significant relationship with clinical stage and histological grade. Tumor diameter, patient age and neoplastic form had no relationship.
  
  
  CONCLUSIONS
  Compared with the Arg/Arg genotypes, the Trp/Trp and Gln/ Gln genotypes could increase the risk of cervical cancer. The Trp or Gln genotypes risk increases. Arg may be a protection factor. The frequencies of Arg399Gln SNP have a correlation with stage and histological grade.
authors.affiliation: Department of Gynecological Oncology, Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China.
authors.forename: Xiao-mei
authors.initials: XM
authors.lastname: Fan
authors.affiliation: Department of Gynecological Oncology, Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China.
authors.forename: Kui-xiu
authors.initials: KX
authors.lastname: Li
authors.affiliation: Department of Gynecological Oncology, Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China.
authors.forename: Shu-huai
authors.initials: SH
authors.lastname: Niu
authors.affiliation: Department of Gynecological Oncology, Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China.
authors.forename: Zhao-hui
authors.initials: ZH
authors.lastname: Fang
authors.affiliation: Department of Gynecological Oncology, Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China. Email: lkxdr@sina.com.
authors.forename: Hong
authors.initials: H
authors.lastname: Liu
mesh_terms: D000328:Adult; D000483:Alleles; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000473:pathology; D016022:Case-Control Studies; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000235:genetics / Q000473:pathology; D000076105:X-ray Repair Cross Complementing Protein 1
chemical_list: D004268:DNA-Binding Proteins; D000076105:X-ray Repair Cross Complementing Protein 1; C000619371:XRCC1 protein, human